Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades

Cancer

Volumn 116, Issue 8, 2010, Pages 1953-1963

  Chen, Zhengshan ^a,b   Huang, Xinrui ^b   Ye, Juxiang ^b   Pan, Peng ^b   Cao, Qi ^b   Yang, Baokai ^b   Li, Zhuo ^b   Su, Meng ^b   Huang, Chen ^b   Gu, Jiang ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cyclin D1; Immunoglobulin G; Ki 67; Proliferating cell nuclear antigen; Soft tissue tumors

Indexed keywords

CYCLIN D1; CYCLINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; KI 67 ANTIGEN; MESSENGER RNA;

ARTICLE; CANCER GRADING; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DERMATOFIBROMA; FIBROMA; FIBROSARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABELING INDEX; LEIOMYOMA; LEIOMYOSARCOMA; LIGHT CHAIN; MAJOR CLINICAL STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE TUMOR;

BASE SEQUENCE; CELL PROLIFERATION; CYCLIN D1; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; KI-67 ANTIGEN; MOLECULAR SEQUENCE DATA; PROLIFERATING CELL NUCLEAR ANTIGEN; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77950974012     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24892     Document Type: Article

References (39)

1. Kimoto Y. Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines. Genes Chromosomes Cancer. 1998;22:83-86. (Pubitemid 28217811)
2. Qiu X, Zhu X, Zhang L, et al. Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 2003;63:6488-6495. (Pubitemid 37255201)
3. Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 2007;21:2931-2938. (Pubitemid 47372759)
4. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 2006;66:3996-4000.
5. Li M, Feng DY, Ren W, et al. Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int J Biochem Cell Biol. 2004;36:2250-2257. (Pubitemid 39094446)
6. Liu HD, Zheng H, Li M, Hu DS, Tang M, Cao Y. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways. Cell Signal. 2007;19:419-427. (Pubitemid 46001832)
7. Zheng H, Li M, Ren W, et al. Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol. 2007;44:2221-2227. (Pubitemid 46097112)
8. Sugiura H, Sato K, Yamamura S, Nagasaka T, Takahashi M, Katagiri H. Proliferating cell nuclear antigen staining as a prognostic indicator in soft-tissue malignant fibrous histiocytoma. Arch Orthop Trauma Surg. 1995;114:248-252.
9. Das P, Kotilingam D, Korchin B, et al. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer. 2007;109:2323-2333. (Pubitemid 46801564)
10. Levine EA, Holzmayer T, Bacus S, et al. Evaluation of newer prognostic markers for adult soft tissue sarcomas. J Clin Oncol. 1997;15:3249-3257. (Pubitemid 27419338)
11. Musella M, Fazioli F, Lombardi S, et al. Assessment of cyclin D1 overexpression as a prognostic factor in soft tissue sarcomas: role of laparoscopy and core needle biopsy. Surg Endosc. 2005;19:1120-1124. (Pubitemid 41494832)
12. Yoo J, Park SY, Kang SJ, Shim SI, Kim BK. Altered expression of G1 regulatory proteins in human soft tissue sarcomas. Arch Pathol Lab Med. 2002;126:567-573. (Pubitemid 34477952)
13. Takahashi Y, Oda Y, Kawaguchi K, et al. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Mod Pathol. 2004;17:660-669. (Pubitemid 38715488)
14. Nieto A, Sanchez MA, Martinez E, Rollan E. Immunohistochemical expression of p53, fibroblast growth factor-b, and transforming growth factor-alpha in feline vaccine-associated sarcomas. Vet Pathol. 2003;40:651-658. (Pubitemid 38393538)
15. Noguchi T, Dobashi Y, Minehara H, Itoman M, Kameya T. Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am J Pathol. 2000;156:2135-2147. (Pubitemid 30641780)
16. Theriault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol. 2000;13:1269-1279. (Pubitemid 32014663)
17. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
18. Zheng H, Li M, Liu H, et al. Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int. 2007;31:82-87. (Pubitemid 46138048)
19. Tokuc G, Dogan O, Ayan I, et al. Prognostic value of proliferating cell nuclear antigen immunostaining in pediatric rhabdomyosarcomas. Acta Paediatr Jpn. 1998;40:573-579. (Pubitemid 29001934)
20. Layfield LJ, Liu K, Dodge R, Barsky SH. Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med. 2000;124:221-227. (Pubitemid 30090606)
21. Dreinhofer KE, Akerman M, Willen H, Anderson C, Gustafson P, Rydholm A. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients. Int J Cancer. 1994;59:379-382. (Pubitemid 24331830)
22. Choong PF, Akerman M, Willen H, et al. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific? APMIS. 1995;103:797-805.
23. Akhan SE, Yavuz E, Tecer A, et al. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study. Gynecol Oncol. 2005;99:36-42.
24. Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM, Brennan MF. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer. 1998;83:490-497. (Pubitemid 28354505)
25. Hoos A, Stojadinovic A, Mastorides S, et al. High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer. 2001;92:869-874. (Pubitemid 32783075)
26. Engellau J. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of wholetumor sections and time-dependence. Acta Orthop Scand Suppl. 2004;75:2 pages preceding table of contents-52, back cover.
27. Levine EA. Prognostic factors in soft tissue sarcoma. Semin Surg Oncol. 1999;17:23-32. (Pubitemid 29305113)
28. Chou CY, Huang SC, Tsai YC, Hsu KF, Huang KE. Uterine leiomyosarcoma has deregulated cell proliferation, but not increased microvessel density compared with uterine leiomyoma. Gynecol Oncol. 1997;65:225-231.
29. Skytting BT, Bauer HC, Perfekt R, Nilsson G.,. Larsson O. Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma Group register. Br J Cancer. 1999;80:1809-1814. (Pubitemid 29389637)
30. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol. 1990;1:199-206.
31. Kim SH, Lewis JJ, Brennan MF, Woodruff JM, Dudas M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas. Clin Cancer Res. 1998;4:2377-2382. (Pubitemid 28477902)
32. Kim SH, Cho NH, Tallini G, Dudas M, Lewis JJ, Cordon- Cardo C. Prognostic role of cyclin D1 in retroperitoneal sarcomas. Cancer. 2001;91:428-434. (Pubitemid 32099246)
33. Kim SH, Kim JW, Kim YT, Kim JH, Yoon BS, Ryu HS. Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas. Int J Gynaecol Obstet. 2006;95:272-277.
34. Anderson SE, Nonaka D, Chuai S, et al. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. Int J Gynecol Cancer. 2006;16:849-853.
35. Staibano S, Franco R, Tranfa F, et al. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior Anticancer Res. 2004;24:249-257.
36. O'Reilly PE, Raab SS, Niemann TH, Rodgers JR, Robinson RA. p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas. Mod Pathol. 1997;10:91-97. (Pubitemid 27110032)
37. Golouh R, Bracko M, Novak J. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas. Mod Pathol. 1996;9:919-924. (Pubitemid 26319722)
38. Leiser AL, Anderson SE, Nonaka D, et al. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol. 2006;101:86-91. (Pubitemid 43303564)
39. Ahlen J, Wejde J, Brosjo O, et al. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Clin Cancer Res. 2005;11:206-216. (Pubitemid 40075797)